Downregulated expression of AD-related genes (APP, PS1, APH1, APOE, IDE, BACE1). Suppressed neuroinflammation: Reduced expression of pro-inflammatory factors (IL-6, IL-1β, TNF-α) and increased expression of the anti-inflammatory factor IL-10. This evidence concerns the gene IDE and Alzheimer disease.